October 1, 2010 – The U.S. Food and Drug Adminstration (FDA) Center for Drug Evaluation and Research (CDER) has awarded two contracts to support the agency’s review of cardiac safety data. Both contracts were given to Mortara Instrument.
October 1, 2010 – An early-warning system for detecting coronary occlusion has received the CE mark for commercial sale in Europe. The AngelMed Guardian System, by Angel Medical Systems, is designed to detect coronary occlusion from thrombotic events, such as plaque ruptures, and alert the patient, often before any symptoms occur.
September 30, 2010 – New angiography navigation tools for structural heart cases were shown by GE Healthcare during last week's Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.
September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient management.
September 30, 2010 – The U.S. Food and Drug Administration (FDA) has cleared a software interface and image segmentation system that can help simulate and evaluate surgical treatment options.
September 29, 2010 – A new portable, arm-held ultrasound system can provide fast, easy and reliable diagnosis even in critical emergency situations. The MyLabOne, by Biosound Esaote, is lightweight and features a 12-inch, color, touch-screen display.
September 29, 2010 - Preclinical data of a therapy designed to treat drug-resistant hypertension was presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium in Washington, D.C.
September 29, 2010 – Physicians from the Cedars-Sinai Heart Institute will lead a clinical trial evaluating transcatheter aortic valve implantation (TAVI) for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery. The trial will study St. Jude Medical’s transcatheter aortic valve.
September 29, 2010 – Results from a trial studying the effects of a drug-eluting balloon (DEB) on peripheral artery disease (PAD) were released at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.
Transcatheter valve therapies were among the hottest topics at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) symposium and the key presentation was the very positive first release of data from the U.S. PARTNER trial. The trial results are widely expected to open the door to a major transition away from surgical to transcatheter aortic valve repair in the coming years.
If you enjoy this content, please share it with a colleague